Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 3/20 | 0.46 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 4/20 | 0.41 |
| ▸ | TMPRSS15 | P98073 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5118218 | 0.91 | LMNA (0.49) | CASP3SLC15A1LMNATDP1L3MBTL1 | |
| SCHEMBL25491972 | 0.83 | S1PR1 (0.49) | SLC15A1LMNATDP1L3MBTL1CASP1 | |
| SCHEMBL5113817 | 0.82 | MEN1 (0.48) | CASP3LMNATDP1L3MBTL1EPHX1 | |
| SCHEMBL8682005 | 0.78 | L3MBTL1 (0.58) | LMNATDP1L3MBTL1TSHR | |
| SCHEMBL30826538 | 0.78 | TMPRSS15 (0.46) | LMNATDP1CASP1TMPRSS15 | |
| Aspartic Acid SCHEMBL28852564 | 0.77 | SLC15A1 (0.56) | SLC15A1L3MBTL1CASP1 | |
| SCHEMBL18775045 | 0.75 | PSMB5 (0.60) | TSHR | |
| SCHEMBL24832472 | 0.75 | L3MBTL1 (0.53) | LMNATDP1L3MBTL1EPHX1 | |
| SCHEMBL18791071 | 0.75 | PSMB5 (0.60) | TSHR | |
| SCHEMBL27873595 | 0.75 | LTA4H (0.54) | SLC15A1TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1313716-A1 | OXAZOLYL-ARYLPROPIONIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS | ELI LILLY AND COMPANY (US) | 2003-05-28 | — | — | EP | disclosed |
| WO-2002016331-A1 | OXAZOLYL-ARYLPROPIONIC ACID DERIVATIVES AND THEIR USE AS PPAR AGONISTS | ELI LILLY AND COMPANY (US) | 2002-02-28 | — | — | WO | disclosed |